This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scholl, F. A. Articles by Schäfer, B. W. Search for Related Content PubMed PubMed Citation Articles by Scholl, F. A. Articles by Schäfer, B. W.

PAX3 Is Expressed in Human Melanomas and Contributes to Tumor Cell Survival¹

Division of Clinical Chemistry and Biochemistry, Department of Pediatrics, University of Zurich [F. A. S., O. V. M., B. W. S.], Department of Dermatology, University Hospital [J. K., R. G., R. D.], and Medica, Department of Molecular Diagnostics [R. G.], CH-8032 Zurich, Switzerland

Deregulated expression of the transcription factor PAX3 was observed previously in several tumors like rhabdomyosarcoma and Ewing’s sarcoma. Because PAX3 expression is also found in pluripotent neural crest cells, we investigated whether melanomas, tumors derived mostly from cutaneous intraepidermal melanocytes, might show deregulated PAX3 expression. Using a specific and sensitive reverse transcription-PCR, we detected PAX3 mRNA in 77% (27 of 35) of primary cultured melanomas. These results could be confirmed by direct in situ hybridization on the corresponding tissue sections where PAX3 expression was unambiguously confined to tumor cells and not detected in surrounding normal tissue, normal skin sections, or sections of benign lesions. Furthermore, down-regulation of PAX3 expression achieved through a specific antisense oligonucleotide-based treatment resulted in >70% of dead cells specifically in PAX3-positive melanomas. Annexin V staining confirmed that primary melanoma cells underwent apoptosis after treatment. These experiments suggest that in situ hybridization of PAX3 on paraffin-embedded tissue may represent a novel means to identify melanoma cell lesions, which appear to become dependent on expression of this deregulated transcription factor.

This article has been cited by other articles:

				Q. Wang, S. Kumar, M. Slevin, and P. Kumar Functional Analysis of Alternative Isoforms of the Transcription Factor PAX3 in Melanocytes In vitro. Cancer Res., September 1, 2006; 66(17): 8574 - 8580. [Abstract] [Full Text] [PDF]

				K. Koyanagi, S. J. O'Day, R. Gonzalez, K. Lewis, W. A. Robinson, T. T. Amatruda, H.-J. Wang, R. M. Elashoff, H. Takeuchi, N. Umetani, et al. Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial J. Clin. Oncol., November 1, 2005; 23(31): 8057 - 8064. [Abstract] [Full Text] [PDF]

				S.-J. He, G. Stevens, A. W. Braithwaite, and M. R. Eccles Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity Mol. Cancer Ther., June 1, 2005; 4(6): 996 - 1003. [Abstract] [Full Text] [PDF]

				K. Koyanagi, C. Kuo, T. Nakagawa, T. Mori, H. Ueno, A. R. Lorico Jr, H.-J. Wang, E. Hseuh, S. J. O'Day, and D. S.B. Hoon Multimarker Quantitative Real-Time PCR Detection of Circulating Melanoma Cells in Peripheral Blood: Relation to Disease Stage in Melanoma Patients Clin. Chem., June 1, 2005; 51(6): 981 - 988. [Abstract] [Full Text] [PDF]

				F. B. Baumann Kubetzko, C. di Paolo, C. Maag, R. Meier, B. W. Schafer, D. R. Betts, R. A. Stahel, and A. Himmelmann The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line Carcinogenesis, October 1, 2004; 25(10): 1839 - 1846. [Abstract] [Full Text] [PDF]

				H. Takeuchi, D. L. Morton, C. Kuo, R. R. Turner, D. Elashoff, R. Elashoff, B. Taback, A. Fujimoto, and D. S.B. Hoon Prognostic Significance of Molecular Upstaging of Paraffin-Embedded Sentinel Lymph Nodes in Melanoma Patients J. Clin. Oncol., July 1, 2004; 22(13): 2671 - 2680. [Abstract] [Full Text] [PDF]

				A. K. Kamaraju, S. Adjalley, P. Zhang, J. Chebath, and M. Revel C/EBP-{delta} Induction by gp130 Signaling: ROLE IN TRANSITION TO MYELIN GENE EXPRESSING PHENOTYPE IN A MELANOMA CELL LINE MODEL J. Biol. Chem., January 30, 2004; 279(5): 3852 - 3861. [Abstract] [Full Text] [PDF]

				R. G. Harris, E. White, E. S. Phillips, and K. A. Lillycrop The Expression of the Developmentally Regulated Proto-oncogene Pax-3 Is Modulated by N-Myc J. Biol. Chem., September 13, 2002; 277(38): 34815 - 34825. [Abstract] [Full Text] [PDF]

				A. K. Kamaraju, C. Bertolotto, J. Chebath, and M. Revel Pax3 Down-regulation and Shut-off of Melanogenesis in Melanoma B16/F10.9 by Interleukin-6 Receptor Signaling J. Biol. Chem., April 19, 2002; 277(17): 15132 - 15141. [Abstract] [Full Text] [PDF]

				L. Pani, M. Horal, and M. R. Loeken Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis Genes & Dev., March 15, 2002; 16(6): 676 - 680. [Abstract] [Full Text] [PDF]